Primary Recommendations

Gaming Realms - Licencing revenue +80% in April and May

July 2020

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

Sometimes shares in a company entering a high growth market can look horribly expensive. They can stay looking horribly expensive but the share price continues to rise and the PE begins to expand and a speculative bubble develops. You only need to look at my recent recommendation of GAN, which is presently trading at the equivalent of 524p versus the tip price of 51.5p in March ‘19.I mention GAN not because I am ready for a bout of chest thumping but because that share has changed the lives of some SCSW subscribers. Maybe that's an exaggeration - but judging from some comments, it has made some of them a lot of money very quickly. For a long time, GAN left investors cold. But I knew when I did the write up that it was their ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Codemasters - Scope for PE to expand

UP Global Sourcing

Gaming Realms (May 2024)

Gaming Realms (October 2023)

Gaming Realms (February 2022)

Gaming Realms (October 2021)

Gaming Realms (February 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X